IRYS 24-hour volatility reaches 41.3%: price rebounds from a low of $0.02424 to a high of $0.03424, trading volume increases to around $7.5 million
Bitget Pulse2026/04/13 07:00Brief Volatility Summary
IRYS experienced significant price volatility over the past 24 hours, with a low of $0.02424 and a high of $0.03424. The current price is $0.03407, reflecting a 41.3% price swing. The 24-hour trading volume is approximately $7.22–7.78 million, with a market capitalization of about $52–65 million and roughly 14,350 holders.
Analysis of Unusual Movements
- No direct news events such as official announcements, partnerships, airdrops, or network upgrades were observed in the past 24 hours.
- Trading volume has significantly increased to around $7.5 million compared to previous periods, possibly accompanied by active market buying.
- No on-chain whale large transfers or abnormal activities were reported in the past 24 hours.
Market Views and Outlook
The CoinGecko community sentiment leans bearish, with a 7-day increase of 29% but only a slight 24-hour rebound of 2.3%. Discussions on the X platform were limited over the past 24 hours, and no mainstream analysts' predictions were observed. Recently (prior to April 11), some traders noted an 8-fold increase in buying volume and accumulation signals from smart wallets, but caution is advised regarding short-term volatility risks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
Crypto prices
More
